Back to Top
Lusvertikimab Biosimilar - Research Grade
$315.00 - $19,890.00
Lusvertikimab Biosimilar - Research Grade
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
≥95% monomer by analytical SEC, >95% by SDS Page
Species Reactivity
Human
Target
IL-7RA
Concentration
5mg/ml
Isotype
Human IgG4 (S228P/L445P)-Kappa
Host
CHO Cells
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Applications
Functional Assays
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity
Detects human IL-7RA
Shipping Conditions
Blue ice
Background
Interleukin-7 receptor alpha (IL-7RA) drives lymphocyte development and homeostasis and is an active target in immunology and autoimmune research. This recombinant anti-human IL-7RA monoclonal is an unconjugated, non-therapeutic analog of lusvertikimab, intended for research use only (RUO). It is manufactured to in vivo standards, carries a low-endotoxin profile, and is offered in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Researchers apply it in functional assays, receptor-blockade and lymphocyte-signalling studies, defined controls, and in vivo models of immune-mediated disease, relying on its reproducibility for extended, high-volume experimental programmes.
Uniprot
P16871
Buffer
ICH3002
Sequence
https://www.imgt.org/mAb-DB/
Write Your Own Review


















